These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7948589)

  • 1. Resorbable polymeric microspheres for drug delivery--production and simultaneous surface modification using PEO-PPO surfactants.
    Coombes AG; Scholes PD; Davies MC; Illum L; Davis SS
    Biomaterials; 1994 Jul; 15(9):673-80. PubMed ID: 7948589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
    Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS
    Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres.
    Rosa GD; Iommelli R; La Rotonda MI; Miro A; Quaglia F
    J Control Release; 2000 Nov; 69(2):283-95. PubMed ID: 11064135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants.
    Rafati H; Lavelle EC; Coombes AG; Stolnik S; Holland J; Davis SS
    Vaccine; 1997 Dec; 15(17-18):1888-97. PubMed ID: 9413098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. About mean diameter and size distributions of poly(lactide-co-glycolide) (PLG) microspheres.
    Berchane NS; Jebrail FF; Carson KH; Rice-Ficht AC; Andrews MJ
    J Microencapsul; 2006 Aug; 23(5):539-52. PubMed ID: 16980275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein spray-freeze drying. Effect of atomization conditions on particle size and stability.
    Costantino HR; Firouzabadian L; Hogeland K; Wu C; Beganski C; Carrasquillo KG; Córdova M; Griebenow K; Zale SE; Tracy MA
    Pharm Res; 2000 Nov; 17(11):1374-83. PubMed ID: 11205730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method.
    Niwa T; Takeuchi H; Hino T; Kunou N; Kawashima Y
    J Pharm Sci; 1994 May; 83(5):727-32. PubMed ID: 8071830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of protein in PLG-microspheres with retention of bioactivity.
    Sturesson C; Carlfors J
    J Control Release; 2000 Jul; 67(2-3):171-8. PubMed ID: 10825551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions.
    Berkland C; Kim K; Pack DW
    J Control Release; 2001 May; 73(1):59-74. PubMed ID: 11337060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
    Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
    Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of surface modification and 3D fabrication techniques to prepare patterned poly(L-lactide) substrates allowing regionally selective cell adhesion.
    Park A; Wu B; Griffith LG
    J Biomater Sci Polym Ed; 1998; 9(2):89-110. PubMed ID: 9493839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size.
    Shiga K; Muramatsu N; Kondo T
    J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles using supercritical fluids.
    Ghaderi R; Artursson P; Carlfors J
    Eur J Pharm Sci; 2000 Mar; 10(1):1-9. PubMed ID: 10699378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
    Uchida T; Yagi A; Oda Y; Nakada Y; Goto S
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.
    Govender T; Stolnik S; Garnett MC; Illum L; Davis SS
    J Control Release; 1999 Feb; 57(2):171-85. PubMed ID: 9971898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
    Pollauf EJ; Kim KK; Pack DW
    J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide).
    Zweers ML; Engbers GH; Grijpma DW; Feijen J
    J Control Release; 2004 Dec; 100(3):347-56. PubMed ID: 15567501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.